Task: Answer the MCQ question.
Question: Which drug exhibits a -25.319% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a COc1ccc(S(=O)(=O)N2CC(C)N(C(=O)N3CCOCC3)C2)cc1
b CCCn1nnnc1SCC(=O)Nc1ccc(F)cc1
c CC12CN3CC(C)(CN(C1)C3c1ccc(Br)cc1)C2
d CCCn1c(C(C)C)n[nH]c1=S
Answer: b. CCCn1nnnc1SCC(=O)Nc1ccc(F)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1nnnc1SCC(=O)Nc1ccc(F)cc1
CCCn1nnnc1SCC(=O)Nc1ccc(F)cc1
N-(4-fluorophenyl)-2-(1-propyltetrazol-5-yl)sulfanylacetamide